Compounds for the treatment of hepatitis C
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Bristol-Myers Squibb Company
A C C
A61P C07D C07D
inventional inventional inventional
Eric Paul Michael Zhongxing Qian Samuel Guo Weixu Li-Qiang Annapurna Tao
Mull Scola Zhang Zhao Gerritz Li Zhai Sun Pendri Wang